Hyamedix ApS: Financial statements 2019
CVR: 39177749
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Hyamedix ApS (CVR 39177749) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 2,555,519 and a net result of DKK 8,138 compared with DKK 0 the year before. That is an increase of 167.9% compared with the year before. The profit margin was 0.3%. Equity in the 2019 report amounted to DKK 9,138. The solvency ratio was 0.8%.
- Revenue
- DKK 2,555,519
- Gross Profit
- DKK 1,384,490
- Profit/Loss
- DKK 8,138
- Equity
- DKK 9,138
- Total Assets
- DKK 1,154,772
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 2.6 mio. | 1.4 mio. | 8 t. | 9 t. | - |
| 2018 | 954 t. | 353 t. | 0 | 1 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Hyamedix ApS has published its annual report for 2018. Revenue came to DKK 953,788, and the net result was DKK 0.
About Hyamedix ApS
Hyamedix ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Hyamedix IVS. The management consists of Michael Foldager Johansen, Birgit Fuhlendorff and Khadija Schwach-Abdellaoui. The board consists of Michael Foldager Johansen (chair), Jesper Ahlmann Funding Andersen and Khadija Schwach-Abdellaoui. The company's owners include Ginnerup Capital ApS, Vivida ApS and Ginkgo ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,843,335 and a net result of DKK -886,857 compared with DKK -1,370,702 the year before. Equity in the 2025 report amounted to DKK -10,060,273.